Prudential Financial Inc Fortress Biotech, Inc. Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $13,704 - $25,695	-17,130 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.24 - $2.75 $79,484 - $176,275	-64,100 Reduced 78.91%	17,130 $23,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $297,635 - $448,913	-122,990 Reduced 60.22%	81,230 $204,000
Q3 2021 Nov 15, 2021	SELL	$2.82 - $3.7 $81,878 - $107,429	-29,035 Reduced 12.45%	204,220 $657,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $169,050 - $264,684	48,300 Added 26.11%	233,255 $833,000

Q1 2021 May 12, 2021	BUY	$3.16 - $4.89 $404,480 - $625,920	128,000 Added 224.74%	184,955 $653,000
Q4 2020 Feb 16, 2021	BUY	$2.2 - $4.45 $125,301 - $253,449	56,955 New	56,955 $181,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.